DennisA.PriebatMD

PubMed

• 92 citations
  Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab
  Emily Z. Keung, Melissa Amber Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, Steven Attia, Ric...> ;Clinical Cancer Research. 2020 Mar 15
• 22 citations
  Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
  Scott M. Schuetze, Vanessa Bolejack, Dafydd G. Thomas, Margaret von Mehren, Shreyaskumar Patel, Brian L. Samuels, Edwin Choy, Gina Z. D'Amato, Arthur P. Staddon, Krist...> ;JAMA Oncology. 2018 Jun 1
• 756 citations
  Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
  Hussein Abdul-Hassan Tawbi, Melissa Amber Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James C. Hu, Sandra P. D'Angelo, Steven Attia, Richard F. Ri...> ;The Lancet. Oncology. 2017 Nov 1
• 60 citations
  Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma
  Brian L. Samuels, Sant P. Chawla, Neeta Somaiah, Arthur P. Staddon, Keith M. Skubitz, Mohammed M. Milhem, Pamela E. Kaiser, David C. Portnoy, Dennis A. Priebat, Mark S...> ;Cancer. 2017 Dec 1
• 65 citations
  Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup T...
  Michael Heinrich, Cathryn Rankin, Charles D. Blanke, George D. Demetri, Ernest C. Borden, Christopher W. Ryan, Margaret von Mehren, Martin E. Blackstein, Dennis A. Pri...> ;JAMA Oncology. 2017 Jul 1
• 122 citations
  Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).
  Martee L. Hensley, J. Kyle Wathen, Robert G. Maki, Dejka M. Araujo, Gregory Sutton, Dennis A. Priebat, Suzanne George, Robert A. Soslow, Laurence H. Baker> ;Cancer. 2013 Apr 15
• 11 citations
  Current imaging and therapy of malignant soft tissue tumors and tumor-like lesions.
  Francesca D. Beaman, James S. Jelinek, Dennis A. Priebat> ;Seminars in Musculoskeletal Radiology. 2013 Apr 1
• 156 citations
  Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial
  Rashmi Chugh, J. Kyle Wathen, Shreyaskumar Patel, Robert G. Maki, Paul A. Meyers, Scott M. Schuetze, Dennis A. Priebat, Dafydd G. Thomas, Jon A. Jacobson, Brian L. Sam...> ;Clinical Cancer Research. 2010 Oct 1
• 9 citations
  Follicular dendritic cell sarcoma of the neck: case report and review of current diagnostic and management strategies.
  Laleh Amiri-Kordestani, Dennis A. Priebat, Stanley H. Chia> ;Ear, Nose, & Throat Journal. 2010 Jul 1
• 24 citations
  Doxorubicin-induced cardiac toxicity and cardiac rest gated blood pool imaging.
  Marta Aiken, Vijay Suhag, Carlos Garcia, Elmo Acio, Shari Moreau, Dennis A. Priebat, Shyam Chennupati, Douglas Van Nostrand> ;Clinical Nuclear Medicine. 2009 Nov 1
• 171 citations
  Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
  Rashmi Chugh, J. Kyle Wathen, Robert G. Maki, Robert S. Benjamin, Shreyaskumar Patel, Paul A. Myers, Dennis A. Priebat, Denise K. Reinke, Dafydd G. Thomas, Mary L. Keo...> ;Journal of Clinical Oncology. 2009 Jul 1
• 33 citations
  Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy.
  Shilen Lakhani, Lev Davidson, Dennis A. Priebat, Averell H. Sherker> ;Hepatology International. 2008 Oct 2
• Prospective evaluation of prognostic factors for recurrence after complete surgical resection of gastrointestinal stromal tumors (GIST).
  Suhag VS, Perry DJ, Kumar D, Amiri-Kordestani L, Jelinek JS, Priebat DA> ;J. Clin. Oncol.. 2008-05-20
• 511 citations
  Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas
  Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Dennis A. Priebat, Scott H. Okuno, Brian L. Samuels, Michael P. Fanucchi, David C. Harmon, Scott M. Schuetze, Denis...> ;Journal of Clinical Oncology. 2007 Jul 1
• A SARC phase II multicenter trial of imatinib mesylate (IM) in patients with aggressive fibromatosis.
  Chugh R, Maki RG, Thomas DG, Reinke D, Wathen JK, Patel S, Priebat DA, Meyers PA, Benjamin RS, Baker LH> ;J. Clin. Oncol.. 2006-06-20
• A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS).
  Maki RG, Hensley ML, Wathen JK, Patel SR, Priebat DA, Okuno S, Reinke D, Thall PF, Benjamin RS, Baker LH> ;J. Clin. Oncol.. 2006-06-20
• Activity of imatinib mesylate in desmoid tumors: Interim analysis of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial.
  Baker LH, Wathen K, Chugh R, Thomas D, Thall PF, Maki RG, Samuels BL, Meyers PA, Priebat DA, Benjamin RS> ;J. Clin. Oncol.. 2004-07-15
• Imatinib mesylate in soft tissue and bone sarcomas: Interim results of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial.
  Chugh R, Thomas D, Wathen K, Thall PF, Benjamin RS, Maki RS, Samuels BL, Keohan ML, Priebat DA, Baker LH> ;J. Clin. Oncol.. 2004-07-15
• 57 citations
  Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group.
  Scott Okuno, Louise Ryan, John H. Edmonson, Dennis A. Priebat, Ronald H. Blum> ;Cancer. 2003 Apr 15
• 186 citations
  Osteosarcoma: a multidisciplinary approach to diagnosis and treatment.
  James C. Wittig, Jacob Bickels, Dennis A. Priebat, James S. Jelinek, Kristen L Kellar-Graney, Barry M. Shmookler, Martin M. Malawer> ;American Family Physician. 2002 Mar 15
• 71 citations
  Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy.
  Tanir M. Allweis, Marc E. Boisvert, Susan E. Otero, David J. Perry, Norman H. Dubin, Dennis A Priebat> ;American Journal of Surgery. 2002 Mar 1
• 39 citations
  Survival After Induction Chemotherapy and Surgical Resection for High-Grade Soft Tissue Sarcoma. Is Radiation Necessary?
  Robert Mikael Henshaw, Dennis A. Priebat, David J. Perry, Barry M. Shmookler, Martin M. Malawer> ;Annals of Surgical Oncology. 2001 Jul 1
• 6 citations
  Cytotoxic activity of 2',2'-difluorodeoxycytidine (gemcitabine) in poorly differentiated thyroid carcinoma cells
  Matthew D. Ringel, Max Greenberg, Xuwu Chen, Nicole Hayre, Koichi Suzuki, Dennis Priebat, Motoyasu Saji, Kenneth D. Burman> ;Thyroid. 2000 Oct 1
• 12 citations
  Impact of two cycles of preoperative chemotherapy with intraarterial cisplatin and intravenous doxorubicin on the choice of surgical procedure for high-grade bone sarc...
  Martin M. Malawer, Richard G. Buch, Gregory H. Reaman, Dennis Priebat, Barry Potter, Jashvir Khurana, Barry Shmookler, Kathleen Patterson, Richard Schulof> ;Clinical Orthopaedics and Related Research. 1991 Sep 1
• 23 citations
  Splenosis mimicking an intra-abdominal malignancy
  Jeffrey D. White, Arthur N. West, Dennis A. Priebat> ;The American Journal of Medicine. 1989 Dec 1
• Join now to see all